Breaking News: Pfizer applied to the F.D.A. for a two-dose vaccine for children under 5, a move officials backed despite mixed results in a trial.

View in browser | nytimes.com   BREAKING NEWS Pfizer applied to the F.D.A. for a two-dose vaccine for children under 5, a move officials backed despite mixed results in a trial. Tuesday, February 1, 2022 4:35 PM EST In a highly unusual move, federal regulators pressed Pfizer and BioNTech to submit a request for emergency authorization, people familiar with the situation said, even though two doses failed to produce the hoped-for immune response among children aged two to four in a clinical trial. Read the latest   ADVERTISEMENT You received this email because you signed up for NYTimes.com's Breaking News Alerts. To stop receiving these emails, unsubscribe or manage your email preferences. Subscribe to the Times Get the NYT app Change Your Email Privacy Policy Contact Advertise California Notice The New York Times Company, 620 Eighth Avenue, New York, NY 10018